Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02544282Phase 4Completed
Phase 4, randomised, double-blind trial of levobupivacaine in postoperative pain (2 arms), sponsored by GZA Ziekenhuizen Campus Sint-Augustinus. Primary endpoint: Postoperative Pain at 72 hours. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02544282.